Singapore-based AUM Biosciences, having recently closed funding of USD27 million for global cancer drug development, sees a lot of untapped opportunities in Asia and India. “AUM is set to leverage on …
( read original story …)
Search your Hotel
The Singapore News
Singapore-based AUM Biosciences, having recently closed funding of USD27 million for global cancer drug development, sees a lot of untapped opportunities in Asia and India. “AUM is set to leverage on …
( read original story …)
Search your Hotel